ReWalk Robotics Ltd. (RWLK) Can’t Burn Your Long Portfolio. Has Another Strong Session

ReWalk Robotics Ltd. (NASDAQ:RWLK) Logo

The stock of ReWalk Robotics Ltd. (NASDAQ:RWLK) is a huge mover today! The stock increased 7.99% or $0.25 during the last trading session, reaching $3.38. About 599,902 shares traded. ReWalk Robotics Ltd. (NASDAQ:RWLK) has declined 82.71% since August 15, 2018 and is downtrending. It has underperformed by 82.71% the S&P500.
The move comes after 6 months positive chart setup for the $24.64M company. It was reported on Aug, 15 by We have $3.68 PT which if reached, will make NASDAQ:RWLK worth $2.22 million more.

More notable recent ReWalk Robotics Ltd. (NASDAQ:RWLK) news were published by: which released: “ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd – GlobeNewswire” on April 23, 2019, also with their article: “ReWalk Announces Preliminary Fiscal Year 2018 Revenue Nasdaq:RWLK – GlobeNewswire” published on January 14, 2019, published: “Lawsuit for Investors in ReWalk Robotics Ltd (NASDAQ:RWLK) shares announced by Shareholders Foundation – GlobeNewswire” on September 27, 2016. More interesting news about ReWalk Robotics Ltd. (NASDAQ:RWLK) were released by: and their article: “ReWalk files for $75M mixed shelf; shares down 4% premarket – Seeking Alpha” published on May 09, 2019 as well as‘s news article titled: “ReWalk Robotics readies equity offering; shares down 9% after hours – Seeking Alpha” with publication date: February 20, 2019.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company has market cap of $24.64 million. The firm offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It currently has negative earnings. ReWalk Robotics Ltd. markets and sells its products directly to institutions and individuals, as well as through third-party distributors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.